Allogeneic Stem Cell Transplant with minimal-intensity Conditioning in Patients with Cutaneous T-cell Lymphoma. A Single Centre Retrospective Review

被引：0
|
作者：
Gallanagh, Marianne [1 ]
Brown, Amy [1 ]
Pryce, Angharad [1 ]
Szydlo, Richard [2 ]
Morris, Stephen [3 ]
Palanicawandar, Renuka [1 ]
Kanfer, Edward [1 ]
机构：
[1] Imperial Healthcare Trust, London, England
[2] Imperial Coll London, London, England
[3] Guys & St Thomas NHS Fdn Trust, London, England
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P139
引用
收藏
页码：282 / 282
页数：1
相关论文
共 50 条
  • [1] Efficacy of the allogeneic stem cell transplant against cutaneous T-cell lymphoma
    Postorino, M.
    Cantonetti, M.
    Cerretti, R.
    Cudillo, L.
    Picardi, A.
    Franceschini, L.
    De Angelis, G.
    Baliva, G.
    Faccia, S.
    Renzi, D.
    Rizzo, M.
    Arcese, W.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S146 - S146
  • [2] Reduced-intensity conditioning allogeneic transplants for cutaneous T-cell lymphoma
    Soligo, D
    Ibatici, A
    Berti, E
    Morandi, P
    Longhi, E
    Motta, M
    Griffoni, F
    Deliliers, GL
    BONE MARROW TRANSPLANTATION, 2003, 31 : S151 - S151
  • [3] Reduced intensity conditioning allogeneic hematopoietic stem cell transplant could be beneficial to angioimmunoblastic T-cell lymphoma patients with hemophagocytic lymphohistiocytosis
    Jui-Ting Yu
    Wen-Li Hwang
    Ren-Ching Wang
    Chieh-Lin Teng
    Annals of Hematology, 2012, 91 : 805 - 807
  • [4] Reduced intensity conditioning allogeneic hematopoietic stem cell transplant could be beneficial to angioimmunoblastic T-cell lymphoma patients with hemophagocytic lymphohistiocytosis
    Yu, Jui-Ting
    Hwang, Wen-Li
    Wang, Ren-Ching
    Teng, Chieh-Lin
    ANNALS OF HEMATOLOGY, 2012, 91 (05) : 805 - 807
  • [5] Allogeneic Haematopoietic Stem Cell Transplantation for Patients with Cutaneous T-cell Lymphoma
    Vakeva, Liisa
    Niittyvuopio, Riitta
    Leppa, Sirpa
    Heiskanen, Jouni
    Lindstrom, Vesa
    Rankil, Annamari
    Volin, Liisa
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (06) : 816 - 817
  • [6] ALLOGENEIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSED OR CHEMOREFRACTORY T-CELL LYMPHOMA: ROLE OF HIGH INTENSITY CONDITIONING
    Glass, B.
    Hasenkamp, J.
    Jung, W.
    Wilhelm, C.
    Held, G.
    Nickelsen, M.
    Pfreundschuh, M.
    Schmitz, N.
    Truemper, L.
    Wulf, G. G.
    ANNALS OF ONCOLOGY, 2011, 22 : 95 - 95
  • [7] Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant
    Savani, Malvi
    Ahn, Kwang W.
    Chen, Yue
    Ahmed, Sairah
    Cashen, Amanda F.
    Shadman, Mazyar
    Modi, Dipenkumar
    Khimani, Farhad
    Cutler, Corey S.
    Zain, Jasmine
    Brammer, Jonathan E.
    Rezvani, Andrew R.
    Fenske, Timothy S.
    Sauter, Craig S.
    Kharfan-Dabaja, Mohamed A.
    Herrera, Alex F.
    Hamadani, Mehdi
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (02) : 212 - 222
  • [8] Allogeneic stem cell transplantation for patients with advanced primary cutaneous T-cell lymphoma
    Cudillo, L.
    Di Veroli, A.
    Mariotti, B.
    Ceresoli, E.
    Picardi, A.
    Cerretti, R.
    De Angelis, G.
    Rizzo, M.
    Pisani, F.
    Cantonetti, M.
    Lombardo, G.
    Scala, E.
    Arcese, W.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S441 - S441
  • [9] Allogeneic hematopoetic stem cell transplantation after reduced intensity conditioning for patients with indolent or mantle cell lymphoma.
    Schieder, H
    Kröger, N
    Zabelina, T
    Ayuk, F
    Kratochwille, A
    Fehse, B
    Fehse, N
    Stute, N
    Renges, H
    Zander, AR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 589S - 589S
  • [10] Allogeneic stem cell transplantation for advanced primary cutaneous T-cell lymphoma: A systematic review
    Schlaak, M.
    Theurich, S.
    Pickenhain, J.
    Skoetz, N.
    Kurschat, P.
    von Bergwet-Baidon, M.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (01) : 21 - 31
12345